BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8722366)

  • 1. Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences.
    Patri S; Dascalesu C; Chomel JC; Sadoun A; Lacotte L; Tanzer J; Guilhot F; Kitzis A
    Bone Marrow Transplant; 1996 Apr; 17(4):625-32. PubMed ID: 8722366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization and karyotype analysis.
    Wessman M; Popp S; Ruutu T; Volin L; Cremer T; Knuutila S
    Bone Marrow Transplant; 1993 Apr; 11(4):279-84. PubMed ID: 8485475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT.
    Pugatsch T; Oppenheim A; Slavin S
    Bone Marrow Transplant; 1996 Feb; 17(2):273-5. PubMed ID: 8640178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
    Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
    Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
    Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta MR; Vittone A; Terragna C; Pignatti PF; Tura S
    Haematologica; 1997; 82(2):156-60. PubMed ID: 9175318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques.
    Viard F; Merel P; Bilhou-Nabera C; Marit G; Comeau F; Gharbi MJ; Febrer F; Belloc F; Lacombe F; Broustet A
    Bone Marrow Transplant; 1993 Jan; 11(1):27-31. PubMed ID: 8431708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation.
    Mangioni S; Balduzzi A; Rivolta A; Rovelli A; Nesi F; Rossi V; Busca A; Uderzo C; Miniero R; Biondi A
    Bone Marrow Transplant; 1997 Dec; 20(11):969-73. PubMed ID: 9422477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of recipient cells after non T-cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has a different prognostic value.
    Landman-Parker J; Socie G; Petit T; Raynal B; Bourhis JH; Pico J; Brison O
    Leukemia; 1994 Nov; 8(11):1989-94. PubMed ID: 7967743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of the analysis of cellular chimerism following bone marrow graft by amplification of minisatellite sequences or specific of the Y chromosome].
    Lasfargues G; Landman Parker J; Blaise A; Brison O; Leverger G
    Bull Acad Natl Med; 1995 Feb; 179(2):357-65; discussion 365-6. PubMed ID: 7614063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
    Verdonck LF; van Blokland WT; Bosboom-Kalsbeek EK; van Heugten HG; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1996 Aug; 18(2):389-95. PubMed ID: 8864451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
    Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation.
    Chalmers EA; Sproul AM; Mills KI; Gibson BE; Burnett AK
    Bone Marrow Transplant; 1990 Dec; 6(6):399-403. PubMed ID: 2097008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.